Conceptus, Inc. (NASDAQ:CPTS)

emeraldvale (< 20) Submitted: 8/30/2011 9:33:12 AM : Start Price: $10.72 CPTS Score: +47.78

ms screen

icrazy (< 20) Submitted: 6/7/2011 1:18:47 PM : Start Price: $13.17 CPTS Score: +25.96

Call me crazy, but it looks as if this one is gaining some momentum upward.

medsmall (30.05) Submitted: 4/5/2011 9:49:22 AM : Start Price: $14.63 CPTS Score: +15.87

Price/earnings of 5.63, market cap of 454.36 million, Debt/equity of 0.53, Return on Invested Capital (TTM) of 41.08, based in California, United States, focus on minimally invasive devices for reproductive medical applications.

colonel79 (< 20) Submitted: 1/11/2010 2:26:43 PM : Start Price: $18.08 CPTS Score: -22.25

This stock has all the forces pushing it to success:
-Little to no debt
-Strong growth
-Recent positive earnings
-Liberal governments that will reimburse them for helping women prevent unwanted children
-Economic forces that will limit the number of children people want to have
-Other procedures available for women to prevent unwanted pregnancies involve chemicals, pills, are surgery and this is cheaper than the alternatives
-Company has patents
-Proven need for these products
-P/E is currently high, but net income to increase 128% in 2010.

Slam dunk and I will probably by this with my own money.

freebirdrenee (< 20) Submitted: 10/13/2008 4:38:08 AM : Start Price: $12.48 CPTS Score: -8.60

For a woman who is certain they do not want any more children this is the way to go! Insurance Companies are already on board and it is being used world wide. Medicade is also paying for this procedure and the government is always the last to sign on to pay for a procedure. This is an in-office procedure does not require any time off to recover therefore less time off from work. Additionally this is great for the women who have small children at home because you don't have any restrictions after the procedure.

dmoromisato (53.99) Submitted: 6/3/2008 4:20:04 PM : Start Price: $18.01 CPTS Score: -5.91

New standard in permanent birth control, if the Buffet Foundation can recognize, it will be standard in the world.

Waynoooo (56.76) Submitted: 1/14/2008 7:37:08 PM : Start Price: $16.01 CPTS Score: +6.64

Marketing a radical form of birth control, making choice easier for all women

brentan0 (60.16) Submitted: 10/22/2007 11:37:56 AM : Start Price: $19.40 CPTS Score: -5.75

Looks undervalued, with next years Q1 earnings estimated 72% above this year's.

rxrobert1 (62.24) Submitted: 3/29/2007 10:17:18 AM : Start Price: $19.55 CPTS Score: -12.05

only manufacturer of current product

skillcat (< 20) Submitted: 12/9/2006 1:45:32 PM : Start Price: $21.88 CPTS Score: -22.22

proven needed product.

bigtalldaddy (42.22) Submitted: 10/27/2006 11:50:33 AM : Start Price: $19.83 CPTS Score: -16.61

i am an OB/GYN MD and with the movement of the Essure procedure into the office setting i expect to continue to see triple digit revenue growth quarter over quarter over the next 2-3 years.

wbce1866 (< 20) Submitted: 9/19/2006 4:07:15 AM : Start Price: $17.59 CPTS Score: -10.44

Women guide family healthcare. They call the shots and this is what they'll want.